Edrophonium antagonism of cisatracurium-induced neuromuscular block: Dose requirements in children and adults

Anaesthesia and Intensive Care

Volumn 29, Issue 4, 2001, Pages 364-370

  Abdulatif, M ^a   El Sanabary, M ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Anaesthesia: Paediatric; Antagonists: Neuromuscular block; Edrophonium; Neuromuscular block: Cisatracurium

Indexed keywords

ATROPINE; CHOLINESTERASE INHIBITOR; CISATRACURIUM; DIAZEPAM; EDROPHONIUM; FENTANYL; ISOFLURANE; MIDAZOLAM; NITROUS OXIDE; PROPOFOL;

ACCELEROMETER; ADULT; ANESTHETIC RECOVERY; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; HUMAN; MAJOR CLINICAL STUDY; MUSCLE RELAXATION; MUSCLE TWITCH; NEUROMUSCULAR BLOCKING; PATIENT MONITORING; RANDOMIZED CONTROLLED TRIAL; TIME;

EID: 0034909960     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0102900406     Document Type: Article

References (28)

1. The use of d-tubocurarine in neonatal anaesthesia
2. The neuromuscular pharmacology of neostigmine in infants and children
3. Reversal of doxacurium and pancuronium neuromuscular blockade with neostigmine in children
4. Dose-response relationships for neostigmine antagonism of rocuronium-induced neuromuscular blockade in children and adults
5. Dose responses for neostigmine and edrophonium as antagonists of mivacurium in adults and children
6. Neuromuscular blocking agents in paediatric anaesthesia
7. A comparison of the neuromuscular blocking effects and reversibility of cisatracurium and atracurium
8. Effects of cisatracurium in children during halothane-nitrous oxide anesthesia
9. The clinical neuromuscular pharmacology of cisatracurium versus vecuronium during outpatient anesthesia
10. The minimum anesthetic concentration of isoflurane in children
11. Effect of edrophonium and neostigmine on the pharmacokinetics and neuromuscular effects of mivacurium
12. Muscle relaxants in the extremes of age
13. Onset of action of relaxants
14. Attempted acceleration of the onset of action of pancuronium: Effects of divided doses in infants and children
15. Clinical pharmacology of edrophonium in infants and children
16. Determinants of the reversal time of competitive neuromuscular block by anticholinesterases
17. Dose-response relationships for edrophonium and neostigmine as antagonists of atracurium and vecuronium neuromuscular blockade
18. Sevoflurane and isoflurane impair edrophonium reversal of vecuronium-induced neuromuscular block
19. Reversal of neuromuscular blockade
20. Reversal of atracurium neuromuscular block in paediatric patients
21. Dose-responses for edrophonium antagonism of vecuronium block in young and older adult patients
22. The maximum depth of an atracurium neuromuscular block antagonised by edrophonium to effect adequate recovery
23. The effect of tubocurarine on indirect elicited train-of-four muscle response and respiratory measurements in humans
24. Postoperative residual curarization and evidence-based anaesthesia
25. Surrogate endpoints and neuromuscular recovery
26. Indicators of recovery of neuromuscular function: Time for change?
27. Is it always necessary to antagonize residual neuromuscular block? Do children differ from adults?
28. Functional assessment of the pharynx at rest and during swallowing in partially paralyzed humans: Simultaneous videomanometry and mechanomyography of awake human volunteers